906 followers
New article: An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naive patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations https://t.co/lkvRoBZQ9V #lungcancer #oncology https://t.